Kaurenoic acid
CAS No. 6730-83-2
Kaurenoic acid ( CCRIS 1514; Kauren-19-oic acid )
Catalog No. M18978 CAS No. 6730-83-2
Kaurenoic acid has anti-inflammatory potential in acetic acid-induced colitis, decreases in MDA level.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 53 | In Stock |
|
10MG | 87 | In Stock |
|
25MG | 158 | In Stock |
|
50MG | 236 | In Stock |
|
100MG | 350 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameKaurenoic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionKaurenoic acid has anti-inflammatory potential in acetic acid-induced colitis, decreases in MDA level.
-
DescriptionKaurenoic acid has anti-inflammatory potential in acetic acid-induced colitis, decreases in MDA level. Kaurenoic acid exerts a uterine relaxant effect acting principally through calcium blockade and in part, by the opening of ATP-sensitive potassium channels. Kaurenoic acid exhibits an analgesic effect in a consistent manner and that its mechanisms involve the inhibition of cytokine production and activation of the NO-cyclic GMP-protein kinase G-ATP-sensitive potassium channel signaling pathway. Kaurenoic acid derivatives have an antimicrobial activity of substituted on carbon-15 at concentrations greater than or equal to 250 μg/ml. Kaurenoic acid has inhibitory effects on the LPS-induced inflammatory response in RAW264.7 macrophages.
-
SynonymsCCRIS 1514; Kauren-19-oic acid
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number6730-83-2
-
Formula Weight302.45
-
Molecular FormulaC20H30O2
-
Purity98%
-
Solubility——
-
SMILESC[C@@]12CCC[C@@]([C@H]1CC[C@]34[C@H]2CC[C@H](C3)C(=C)C4)(C)C(=O)O
-
Chemical Name(4R,4aS,6aS,9S,11aR,11bS)-4,11b-dimethyl-8-methylenetetradecahydro-6a,9-methanocyclohepta[a]naphthalene-4-carboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Okoye T C, et al. Anticonvulsant effect of kaurenoic acid isolated from the root bark of Annona senegalensis.[J]. Pharmacology Biochemistry & Behavior, 2013, 109(8):38-43.
molnova catalog
related products
-
2-Methylbenzene-1-su...
Used for saccharin, pharmaceutical intermediates, etc.
-
GSK-626616
GSK-626616 is a potent and orally bioavailable DYRK3 inhibitor (IC50: 0.7 nM). It inhibits other members of the DYRK family with similar potency. GSK-626616 is a potential therapy for the treatment of anemia.
-
Myristic acid
Myristic Acid, a 14 carbon saturated fatty acid, is a rare molecule in cells and is a substrate of some fatty acid desaturases.